Denmark vs Gambia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Denmark
0.1%
in 2024
Gambia
0.1%
in 2024
Denmark rank
112th
Gambia rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Denmark
- Gambia
How they compare
Denmark currently reports 0.1% against 0.1% in Gambia, a difference of 0.0%.
Across all 10 years both countries report, Gambia has been ahead every year.
Denmark ranks 112th and Gambia ranks 112th of 215 countries.
Gambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.2% | 0.1% | Gambia |
| 2020s | 0.1% | 0.2% | 0.1% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Denmark or Gambia?
- Denmark, at 0.1% against 0.1% in Gambia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Denmark and Gambia?
- 0.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Gambia?
- 10 years are reported by both, from 2015 to 2024.
- How do Denmark and Gambia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Denmark ranks 112th and Gambia ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.